Fetal Nasal Bone Hypoplasia in the Second Trimester as a Marker of Multiple Genetic Syndromes

Nasal bone hypoplasia is associated with a trisomy of chromosome 21, 18 or 13. Nasal bone hypoplasia can also be seen in other, rarer genetic syndromes. The aim of the study was to evaluate the potential of nasal bone hypoplasia, in the second trimester of pregnancy, as a marker of fetal facial dysm...

Full description

Bibliographic Details
Main Authors: Hanna Moczulska, Marcin Serafin, Katarzyna Wojda, Maciej Borowiec, Piotr Sieroszewski
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/11/6/1513
_version_ 1797470548175880192
author Hanna Moczulska
Marcin Serafin
Katarzyna Wojda
Maciej Borowiec
Piotr Sieroszewski
author_facet Hanna Moczulska
Marcin Serafin
Katarzyna Wojda
Maciej Borowiec
Piotr Sieroszewski
author_sort Hanna Moczulska
collection DOAJ
description Nasal bone hypoplasia is associated with a trisomy of chromosome 21, 18 or 13. Nasal bone hypoplasia can also be seen in other, rarer genetic syndromes. The aim of the study was to evaluate the potential of nasal bone hypoplasia, in the second trimester of pregnancy, as a marker of fetal facial dysmorphism, associated with pathogenic copy number variation (CNV). This retrospective analysis of the invasive tests results in fetuses with nasal bone hypoplasia, after excluding those with trisomy 21, 18 and 13. In total, 60 cases with nasal bone hypoplasia were analyzed. Chromosomal aberrations were found in 7.1% of cases of isolated nasal bone hypoplasia, and in 57% of cases of nasal bone hypoplasia with additional malformations. Additionally, in four of nine cases with non-isolated nasal bone hypoplasia but normal CMA results, a monogenic disease was diagnosed. Non-isolated hypoplastic nasal bone appears to be an effective objective marker of fetal facial dysmorphism, associated with pathogenic CNVs or monogenic diseases. In isolated cases, chromosomal microarray testing can be of additional value if invasive testing is performed, e.g., for aneuploidy testing after appropriate counseling.
first_indexed 2024-03-09T19:38:20Z
format Article
id doaj.art-a8aabec9f2d3441ab4c003a0a244fb73
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-09T19:38:20Z
publishDate 2022-03-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-a8aabec9f2d3441ab4c003a0a244fb732023-11-24T01:47:18ZengMDPI AGJournal of Clinical Medicine2077-03832022-03-01116151310.3390/jcm11061513Fetal Nasal Bone Hypoplasia in the Second Trimester as a Marker of Multiple Genetic SyndromesHanna Moczulska0Marcin Serafin1Katarzyna Wojda2Maciej Borowiec3Piotr Sieroszewski4Department of Clinical Genetics, Medical University of Lodz, 90-419 Lodz, PolandDepartment of Clinical Genetics, Medical University of Lodz, 90-419 Lodz, PolandDepartment of Fetal Medicine and Gynecology, Medical University of Lodz, 90-419 Lodz, PolandDepartment of Clinical Genetics, Medical University of Lodz, 90-419 Lodz, PolandDepartment of Fetal Medicine and Gynecology, Medical University of Lodz, 90-419 Lodz, PolandNasal bone hypoplasia is associated with a trisomy of chromosome 21, 18 or 13. Nasal bone hypoplasia can also be seen in other, rarer genetic syndromes. The aim of the study was to evaluate the potential of nasal bone hypoplasia, in the second trimester of pregnancy, as a marker of fetal facial dysmorphism, associated with pathogenic copy number variation (CNV). This retrospective analysis of the invasive tests results in fetuses with nasal bone hypoplasia, after excluding those with trisomy 21, 18 and 13. In total, 60 cases with nasal bone hypoplasia were analyzed. Chromosomal aberrations were found in 7.1% of cases of isolated nasal bone hypoplasia, and in 57% of cases of nasal bone hypoplasia with additional malformations. Additionally, in four of nine cases with non-isolated nasal bone hypoplasia but normal CMA results, a monogenic disease was diagnosed. Non-isolated hypoplastic nasal bone appears to be an effective objective marker of fetal facial dysmorphism, associated with pathogenic CNVs or monogenic diseases. In isolated cases, chromosomal microarray testing can be of additional value if invasive testing is performed, e.g., for aneuploidy testing after appropriate counseling.https://www.mdpi.com/2077-0383/11/6/1513nasal bone hypoplasiainvasive testingprenatal diagnosis
spellingShingle Hanna Moczulska
Marcin Serafin
Katarzyna Wojda
Maciej Borowiec
Piotr Sieroszewski
Fetal Nasal Bone Hypoplasia in the Second Trimester as a Marker of Multiple Genetic Syndromes
Journal of Clinical Medicine
nasal bone hypoplasia
invasive testing
prenatal diagnosis
title Fetal Nasal Bone Hypoplasia in the Second Trimester as a Marker of Multiple Genetic Syndromes
title_full Fetal Nasal Bone Hypoplasia in the Second Trimester as a Marker of Multiple Genetic Syndromes
title_fullStr Fetal Nasal Bone Hypoplasia in the Second Trimester as a Marker of Multiple Genetic Syndromes
title_full_unstemmed Fetal Nasal Bone Hypoplasia in the Second Trimester as a Marker of Multiple Genetic Syndromes
title_short Fetal Nasal Bone Hypoplasia in the Second Trimester as a Marker of Multiple Genetic Syndromes
title_sort fetal nasal bone hypoplasia in the second trimester as a marker of multiple genetic syndromes
topic nasal bone hypoplasia
invasive testing
prenatal diagnosis
url https://www.mdpi.com/2077-0383/11/6/1513
work_keys_str_mv AT hannamoczulska fetalnasalbonehypoplasiainthesecondtrimesterasamarkerofmultiplegeneticsyndromes
AT marcinserafin fetalnasalbonehypoplasiainthesecondtrimesterasamarkerofmultiplegeneticsyndromes
AT katarzynawojda fetalnasalbonehypoplasiainthesecondtrimesterasamarkerofmultiplegeneticsyndromes
AT maciejborowiec fetalnasalbonehypoplasiainthesecondtrimesterasamarkerofmultiplegeneticsyndromes
AT piotrsieroszewski fetalnasalbonehypoplasiainthesecondtrimesterasamarkerofmultiplegeneticsyndromes